Trending NewsTrending NewsNYSE:CNC Centene (CNC) Stock Price, News & Analysis $68.79 +0.76 (+1.11%) Closing price 03:59 PM EasternExtended Trading$69.36 +0.57 (+0.82%) As of 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Centene Stock (NYSE:CNC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Centene alerts:Sign Up Key Stats Today's Range$65.67▼$71.6850-Day Range$60.95▼$71.2152-Week Range$31.63▼$72.50Volume11.67 million shsAverage Volume5.63 million shsMarket Capitalization$33.98 billionP/E RatioN/ADividend YieldN/APrice Target$70.05Consensus RatingHold Company Overview Centene Corporation is a diversified healthcare enterprise that provides government-sponsored and commercial health insurance programs and related healthcare services. The company’s offerings are primarily focused on Medicaid, Medicare, and health insurance marketplace plans, with an emphasis on serving individuals and families who may have limited access to traditional healthcare coverage. Centene operates Medicaid health plans through state-based contracts and offers Medicare Advantage, Medicare prescription drug, and Medicare Supplement products through its Wellcare brand. Its Ambetter brand provides individual and family health plans through the Affordable Care Act marketplace. The company also provides specialty services and healthcare solutions, including behavioral health, pharmacy services, care management, and services for individuals with complex medical needs. The company traces its origins to 1984, when it was established as a nonprofit Medicaid plan in Wisconsin. Centene has since expanded through organic growth and acquisitions into a national managed-care organization serving members across the United States. Its health plans operate in all 50 states, although the products and services available vary by state and applicable government or commercial contracts. Sarah M. London has served as Centene’s chief executive officer since 2022. The company is headquartered in St. Louis, Missouri, and remains focused on coordinating care, improving healthcare access, and managing costs for government-sponsored and other health plan members.AI Generated. May Contain Errors. Read More Centene Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreCNC MarketRank™: 3.051755291685 of 5 starsCentene scored higher than 61% of companies evaluated by MarketBeat, and ranked 324th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingHold Consensus RatingCentene has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 9 buy ratings, 10 hold ratings, and 2 sell ratings.Upside/DownsideThe consensus price target for Centene is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageCentene has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Centene's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth9.20% Earnings GrowthEarnings for Centene are expected to grow by 9.20% in the coming year, from $4.89 to $5.34 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Centene is -6.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Centene is -6.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioCentene has a PEG Ratio of 0.44. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioCentene has a P/B Ratio of 1.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Centene's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.22% of the float of Centene has been sold short.Short Interest Ratio / Days to CoverCentene has a short interest ratio ("days to cover") of 2.53, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Centene has recently increased by 4.01%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCentene does not currently pay a dividend.Dividend GrowthCentene does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.79 News SentimentCentene has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 29 news articles for Centene this week, compared to 8 articles on an average week.Search InterestOnly 14 people have searched for CNC on MarketBeat in the last 30 days. This is a decrease of -7% compared to the previous 30 days.MarketBeat Follows15 people have added Centene to their MarketBeat watchlist in the last 30 days. This is an increase of 88% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Centene insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,891,182.00 in company stock.Percentage Held by Insiders0.37% of the stock of Centene is held by insiders.Percentage Held by Institutions93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Centene's insider trading history. Receive CNC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CNC Stock News HeadlinesCentene Corporation (CNC) Q3 2026 Earnings Call Transcript4 hours ago | seekingalpha.comCentene Stock Approaches 52-Week High on Faster-Than-Expected Earnings RecoveryOctober 27 at 12:30 PM | benzinga.comFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.October 27 at 1:00 AM | Stansberry Research (Ad)Centene Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026October 27 at 10:37 AM | marketscreener.comMCentene lifts annual profit forecast, reports upbeat third-quarter resultsOctober 27 at 10:37 AM | msn.comEarnings Flash (CNC) Centene Corporation Posts Q3 Adjusted EPS $0.58 per ShareOctober 27 at 10:37 AM | marketscreener.comMCentene: Q3 Earnings SnapshotOctober 27 at 10:37 AM | finance.yahoo.comCentene (NYSE:CNC) delivers strong Q3 2026 numbers, full-year outlook slightly exceeds expectationsOctober 27 at 10:37 AM | msn.comSee More Headlines CNC Stock Analysis - Frequently Asked Questions How have CNC shares performed this year? Centene's stock was trading at $41.18 at the beginning of the year. Since then, CNC shares have increased by 67.0% and is now trading at $68.7880. How were Centene's earnings last quarter? Centene Corporation (NYSE:CNC) released its earnings results on Monday, October, 26th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.48. The firm's quarterly revenue was up 1.9% on a year-over-year basis. Read the conference call transcript. When did Centene's stock split? Shares of Centene split before market open on Wednesday, February 6th 2019.The 2-1 split was announced on Tuesday, February 5th 2019. The newly issued shares were issued to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Does Centene have any subsidiaries? Centene subsidiaries include these companies: Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and more. Who are Centene's major shareholders? Centene's top institutional shareholders include Assenagon Asset Management S.A. (0.91%), Robeco Institutional Asset Management B.V. (0.67%), Ninety One UK Ltd (0.30%) and QV Investors Inc. (0.06%). Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Christopher Koster, Theodore R Samuels II, Christopher J Coughlin, Lori Jean Robinson and H James Dallas. View institutional ownership trends. How do I buy shares of Centene? Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Centene own? Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include NVIDIA (NVDA), UnitedHealth Group (UNH), Alibaba Group (BABA), Advanced Micro Devices (AMD), Micron Technology (MU), Visa (V) and PayPal (PYPL). Company Calendar Last Earnings10/26/2026Today10/27/2026Next Earnings (Estimated)10/27/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 CNC's financial health is in the Green zone, according to TradeSmith. CNC has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryManaged Healthcare Current SymbolNYSE:CNC CIK1071739 Webwww.centene.com Phone(314) 725-4477Fax314-558-2428Employees61,100Year Founded1984Price Target and Rating Average Price Target for Centene$70.05 High Price Target$80.00 Low Price Target$40.00 Potential Upside/Downside+1.8%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage21 Analysts Profitability EPS (Trailing Twelve Months)($10.44) Trailing P/E RatioN/A Forward P/E Ratio14.07 P/E Growth0.44Net Income-$6.67 billion Net Margins-2.51% Pretax Margin-2.28% Return on Equity12.12% Return on Assets3.20% Debt Debt-to-Equity Ratio0.71 Current Ratio1.15 Quick Ratio1.15 Sales & Book Value Annual Sales$194.78 billion Price / Sales0.17 Cash Flow$4.59 per share Price / Cash Flow14.98 Book Value$40.76 per share Price / Book1.69Miscellaneous Outstanding Shares493,990,000Free Float492,167,000Market Cap$33.98 billion OptionableOptionable Beta1.13 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NYSE:CNC) was last updated on 10/27/2026 by MarketBeat.com Staff. From Our Partners6 Men Secretly Changed America’s Money. Now It’s Happening AgainIn 1910, six powerful men secretly met to lay the groundwork for the Federal Reserve, reshaping America's fina...Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long...TradeWins | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
